---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-23-000341"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T03:07:06.597724+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lifeloc Tech reports 2022 net loss of $456K despite 20% revenue growth to $8.482M

## Summary
- Revenue $8.482M (+20% YoY); net loss $456K (($0.19)/share) vs net profit $676K ($0.27/share) in 2021.
- One-time gain of $108K from employee retention tax credit in 2022; 2021 had $936K PPP loan forgiveness.
- L-series devices (LX9/LT7) sales grew 360% vs 2021; expected to continue growth.
- SpinDx THC saliva detection testing validates against LCMS at ~10 ng/mL; commercial launch targeted for 2024.
- Supply chain disruptions and higher R&D spending drove loss despite revenue recovery to pre-pandemic levels.

## SEC filing metadata
- accession: 0001079973-23-000341
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997323000341/0001079973-23-000341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997323000341/lclc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-23-000341
- JSON: https://secwatch.observer/filing/0001079973-23-000341.json
- Plain text: https://secwatch.observer/filing/0001079973-23-000341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.